Stock Research: Veru

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Veru

NasdaqCM:VERU US92536C1036
4
  • Value
    37
  • Growth
    23
  • Safety
    Safety
    26
  • Combined
    7
  • Sentiment
    10
  • 360° View
    360° View
    4
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Veru Inc. is a biopharmaceutical company focused on developing medicines for metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its main businesses involve drug development programs for enobosarm and sabizabulin. In the last fiscal year, the company had a market cap of $85 million, profits of $6 million, revenue of $17 million, and 210 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 4 (better than 4% compared with alternatives), overall professional sentiment and financial characteristics for the stock Veru are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with all four indicators below average for Veru. The consolidated Value Rank has a low rank of 26 which means that the share price of Veru is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 74% of alternative stocks in the same industry. The consolidated Growth Rank also has a low rank of 23, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is lower than for 23% of competitors in the same industry. The consolidated Safety Rank has a riskier rank of 37, which means that the company has a riskier financing structure than 63% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a low rank of 10, which means that professional investors are more pessimistic about the stock than for 90% of alternative investment opportunities. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
26 11 10 9
Growth
23 95 3 45
Safety
Safety
37 57 4 66
Sentiment
10 26 12 51
360° View
360° View
4 54 1 27
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
67 64 71 88
Opinions Change
50 83 50 50
Pro Holdings
n/a 33 1 65
Market Pulse
1 1 9 16
Sentiment
10 26 12 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
26 11 10 9
Growth
23 95 3 45
Safety Safety
37 57 4 66
Combined
7 75 1 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
22 22 22 22
Price vs. Earnings (P/E)
13 1 11 33
Price vs. Book (P/B)
47 47 35 62
Dividend Yield
1 1 1 1
Value
26 11 10 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
33 51 1 82
Profit Growth
74 53 55 1
Capital Growth
15 87 7 71
Stock Returns
13 71 5 23
Growth
23 95 3 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
58 64 44 76
Refinancing
55 78 21 71
Liquidity
10 4 13 17
Safety Safety
37 57 4 66

Similar Stocks

Discover high‑ranked alternatives to Veru and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Tyson Foods

NYSE:TSN
Country: USA
Industry: Packaged Foods & Meats
Size: X-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.